Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | ALPG | P10696 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27154411 | 0.92 | KDM4E (0.56) | KDM4ECHRM3ALOX15GAAPOLB | |
| SCHEMBL31708856 | 0.92 | KDM4E (0.56) | KDM4ECHRM3ALOX15GAAPOLB | |
| SCHEMBL27154412 | 0.92 | KDM4E (0.56) | KDM4ECHRM3ALOX15GAAPOLB | |
| SCHEMBL31709174 | 0.88 | CHRM3 (0.46) | KDM4ECHRM3ALOX15GAAPOLB | |
| SCHEMBL31708882 | 0.85 | SIGMAR1 (0.57) | KDM4ECHRM3ALOX15HTTALDH1A1 | |
| SCHEMBL31708621 | 0.84 | MAPT (0.43) | MAPTALPLALPIALPGKDM4E | |
| SCHEMBL31708623 | 0.84 | ALPL (0.47) | MAPTALPLALPIALPGKDM4E | |
| SCHEMBL31709126 | 0.84 | CHRM3 (0.44) | CHRM3 | |
| SCHEMBL31708852 | 0.83 | KDM4E (0.48) | KDM4ECHRM3ALOX15GAAPOLB | |
| SCHEMBL31708922 | 0.82 | KDM4E (0.45) | MAPTKDM4EALOX15POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326744-A1 | PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION | FUJIFILM CORPORATION (JP) | 2025-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326744-A1 | PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION | ABCB11, ABCC1, SLC11A2 | MAPT 2498/4885ALPL 1281/4885ALPI 1000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.